79 related articles for article (PubMed ID: 3305942)
21. Spontaneous secretion of a proteoglycan releasing factor by mononuclear cells in juvenile arthritis.
Silverman ED; Smith RL; Schurman DJ; Miller JJ
J Rheumatol; 1987 Jun; 14(3):540-7. PubMed ID: 3498038
[TBL] [Abstract][Full Text] [Related]
22. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4.
Lubberts E; Joosten LA; van de Loo FA; van den Gersselaar LA; van den Berg WB
Arthritis Rheum; 2000 Jun; 43(6):1300-6. PubMed ID: 10857788
[TBL] [Abstract][Full Text] [Related]
23. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures.
Stefanovic-Racic M; Morales TI; Taskiran D; McIntyre LA; Evans CH
J Immunol; 1996 Feb; 156(3):1213-20. PubMed ID: 8558000
[TBL] [Abstract][Full Text] [Related]
24. The effect of naproxen and interleukin-1 on proteoglycan catabolism and on neutral metalloproteinase activity in normal articular cartilage in vitro.
Glazer PA; Rosenwasser MP; Ratcliffe A
J Clin Pharmacol; 1993 Feb; 33(2):109-14. PubMed ID: 8440758
[TBL] [Abstract][Full Text] [Related]
25. Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo.
Cai L; Yin JP; Starovasnik MA; Hogue DA; Hillan KJ; Mort JS; Filvaroff EH
Cytokine; 2001 Oct; 16(1):10-21. PubMed ID: 11669582
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine.
Badger AM; Cook MN; Swift BA; Newman-Tarr TM; Gowen M; Lark M
J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566
[TBL] [Abstract][Full Text] [Related]
27. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of hyaluronan metabolism by interleukin-1alpha in human articular cartilage.
Nishida Y; D'Souza AL; Thonar EJ; Knudson W
Arthritis Rheum; 2000 Jun; 43(6):1315-26. PubMed ID: 10857790
[TBL] [Abstract][Full Text] [Related]
29. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA
Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
[TBL] [Abstract][Full Text] [Related]
30. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants.
Hui W; Bell M; Carroll G
Cytokine; 1996 Jun; 8(6):495-500. PubMed ID: 8818547
[TBL] [Abstract][Full Text] [Related]
31. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of hyperosmotic challenge on interleukin-1-activated pathways in bovine articular cartilage.
Le D; Hofbauer MA; Towle CA
Arch Biochem Biophys; 2006 Jan; 445(1):1-8. PubMed ID: 16359637
[TBL] [Abstract][Full Text] [Related]
33. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
34. Effects of ceramide on aggrecanase activity in rabbit articular cartilage.
Sabatini M; Thomas M; Deschamps C; Lesur C; Rolland G; de Nanteuil G; Bonnet J
Biochem Biophys Res Commun; 2001 May; 283(5):1105-10. PubMed ID: 11355886
[TBL] [Abstract][Full Text] [Related]
35. IL-1 beta induces the degradation of equine articular cartilage by a mechanism that is not mediated by nitric oxide.
Bird JL; Wells T; Platt D; Bayliss MT
Biochem Biophys Res Commun; 1997 Sep; 238(1):81-5. PubMed ID: 9299456
[TBL] [Abstract][Full Text] [Related]
36. Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage.
Mort JS; Dodge GR; Roughley PJ; Liu J; Finch SJ; DiPasquale G; Poole AR
Matrix; 1993 Mar; 13(2):95-102. PubMed ID: 8492744
[TBL] [Abstract][Full Text] [Related]
37. Effect of methylprednisolone acetate on proteoglycan and collagen metabolism of articular cartilage explants.
Todhunter RJ; Fubini SL; Wootton JA; Lust G
J Rheumatol; 1996 Jul; 23(7):1207-13. PubMed ID: 8823694
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors.
Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ
Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
40. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro.
Andrews HJ; Plumpton TA; Harper GP; Cawston TE
Agents Actions; 1992 Sep; 37(1-2):147-54. PubMed ID: 1456176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
